This inventor holds 1 USPTO granted patent. Top assignee: Deciphera Pharmaceuticals, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Salim Javed: Innovator in Kinase Inhibitors
Introduction
Salim Javed is a notable inventor based in Waltham, Pakistan. He has made significant contributions to the field of biotechnology, particularly in the development of kinase inhibitors. His work is essential for advancing therapeutic methods in various medical applications.
Latest Patents
Salim Javed holds a patent titled "GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF." This patent represents his innovative approach to targeting specific kinases, which can lead to new treatment options for diseases.
Career Highlights
Currently, Salim Javed is associated with Deciphera Pharmaceuticals, LLC. His role at the company allows him to leverage his expertise in kinase inhibitors to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Salim collaborates with talented professionals such as Yu Mi Ahn and Gada Al-Ani. These partnerships enhance the research efforts at Deciphera Pharmaceuticals and foster an environment of innovation.
Conclusion
Salim Javed's work in kinase inhibitors exemplifies the impact of innovative thinking in biotechnology. His contributions are paving the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile